StonvexLoading…
StonvexStonvexStonvexCore line items from ICU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $1.23M | $135.00K | $0.00 |
Operating Income | $-12.18M | $-17.84M | $-14.21M |
Net Income | $-12.15M | $-24.83M | $-26.23M |
EPS (Diluted) | $-5.86 | $-6.63 | $-30.26 |
Total Assets | $14.16M | $4.66M | $3.51M |
Total Liabilities | $3.74M | $6.84M | $17.38M |
Cash & Equivalents | $11.98M | $1.82M | $176.00K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available |
Shares Outstanding | 3.84M | 650.64K | 2.02M |